Back to results
US 2023/0355741 A1Published application
Feline Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine
AssigneeIntervet Inc.
InventorsMark A. Mogler, Ian Tarpey
Life of this patent
Estimating the term…
Abstract
The present invention provides new vaccines for felines and ferrets to aid in reducing shedding of severe acute respiratory syndrome coronavirus 2 by infected felines or ferrets. Methods of making and using the vaccines alone or in combinations with other protective agents are also provided.
Claims19
An immunogenic composition comprising a Venezuelan Equine Encephalitis (VEE) alphavirus RNA replicon particle that encodes a first SARS-CoV-2 protein antigen.
Dependencies are inferred from the claim text.